{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:14Z","timestamp":1792507514948,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1760-3","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T06:52:17Z","timestamp":1544079137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Lebin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9470-0299","authenticated-orcid":false,"given":"Xiaoyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"issue":"9","key":"1760_CR1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358(9):929\u201339.","journal-title":"N Engl J Med"},{"issue":"5","key":"1760_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"RC Lawrence","year":"1998","unstructured":"Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778\u201399.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1760_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1258\/td.2008.080379","volume":"39","author":"J Wang","year":"2009","unstructured":"Wang J, Pan HF, Su H, Li XP, Xu JH, Ye DQ. Tuberculosis in systemic lupus erythematosus in Chinese patients. Trop Dr. 2009;39(3):165\u20137.","journal-title":"Trop Dr"},{"issue":"8","key":"1760_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1191\/0961203303lu1074oa","volume":"13","author":"AM Alahlafi","year":"2004","unstructured":"Alahlafi AM, Wordsworth P, Lakasing L, Davies D, Wojnarowska F. The basement membrane zone in patients with systemic lupus erythematosus: immunofluorescence studies in the skin, kidney and amniochorion. Lupus. 2004;13(8):594\u2013600.","journal-title":"Lupus"},{"issue":"11","key":"1760_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","volume":"56","author":"F Rees","year":"2017","unstructured":"Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford). 2017;56(11):1945\u201361.","journal-title":"Rheumatology (Oxford)"},{"key":"1760_CR6","doi-asserted-by":"crossref","unstructured":"Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE: A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017;31(3):373\u201396.","DOI":"10.1016\/j.berh.2017.09.013"},{"issue":"5","key":"1760_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/BOR.0b013e328363eba3","volume":"25","author":"JS Knight","year":"2013","unstructured":"Knight JS, Kaplan MJ. Cardiovascular disease in lupus: insights and updates. Curr Opin Rheumatol. 2013;25(5):597\u2013605.","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"1760_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MAJ.0b013e31827f4ee3","volume":"346","author":"N Maroz","year":"2013","unstructured":"Maroz N, Segal MS. Lupus nephritis and end-stage kidney disease. Am J Med Sci. 2013;346(4):319\u201323.","journal-title":"Am J Med Sci"},{"issue":"6","key":"1760_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0961203309102556","volume":"18","author":"M Gayed","year":"2009","unstructured":"Gayed M, Bernatsky S, Ramsey-Goldman R, Clarke A, Gordon C. Lupus and cancer. Lupus. 2009;18(6):479\u201385.","journal-title":"Lupus"},{"issue":"9","key":"1760_CR10","first-page":"6270","volume":"7","author":"M Zhang","year":"2014","unstructured":"Zhang M, Li XM, Wang GS, Qian L, Tao JH, Ma Y, Li XP. Thyroid cancer in systemic lupus erythematosus: a meta analysis. Int J Clin Exp Pathol. 2014;7(9):6270\u20133.","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"1760_CR11","doi-asserted-by":"publisher","first-page":"e0179088","DOI":"10.1371\/journal.pone.0179088","volume":"12","author":"JS Yun","year":"2017","unstructured":"Yun JS, Bae JM, Kim KJ, Jung YS, Kim GM, Kim HR, Lee JS, Ko SH, Cha SA, Ahn YB. Increased risk of thyroid diseases in patients with systemic lupus erythematosus: a nationwide population-based study in Korea. PLoS One. 2017;12(6):e0179088.","journal-title":"PLoS One"},{"issue":"4","key":"1760_CR12","first-page":"613","volume":"56","author":"H Wadstrom","year":"2017","unstructured":"Wadstrom H, Arkema EV, Sjowall C, Askling J, Simard JF. Cervical neoplasia in systemic lupus erythematosus: a nationwide study. Rheumatology (Oxford). 2017;56(4):613\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1760_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12026-016-8885-8","volume":"65","author":"S Azrielant","year":"2017","unstructured":"Azrielant S, Tiosano S, Watad A, Mahroum N, Whitby A, Comaneshter D, Cohen AD, Amital H. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study. Immunol Res. 2017;65(2):464\u20139.","journal-title":"Immunol Res"},{"key":"1760_CR14","doi-asserted-by":"crossref","unstructured":"Tallbacka KR, Pettersson T, Pukkala E. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up. Scand J Rheumatol. 2018;47:1\u20134. Epub ahead of print.","DOI":"10.1080\/03009742.2017.1384054"},{"issue":"12","key":"1760_CR15","doi-asserted-by":"publisher","first-page":"1150.e1151","DOI":"10.1016\/j.amjmed.2010.07.003","volume":"123","author":"YJ Chen","year":"2010","unstructured":"Chen YJ, Chang YT, Wang CB, Wu CY. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med. 2010;123(12):1150.e1151\u20136.","journal-title":"Am J Med"},{"issue":"6","key":"1760_CR16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s10067-017-3950-9","volume":"37","author":"Z Rezaieyazdi","year":"2018","unstructured":"Rezaieyazdi Z, Tabaei S, Ravanshad Y, Akhtari J, Mehrad-Majd H. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis. Clin Rheumatol. 2018;37(6):1511\u20139.","journal-title":"Clin Rheumatol"},{"key":"1760_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group P-P. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"issue":"9","key":"1760_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"1760_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28(2):105\u201314.","journal-title":"Contemp Clin Trials"},{"issue":"7129","key":"1760_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7129):629\u201334.","journal-title":"BMJ"},{"issue":"18","key":"1760_CR21","doi-asserted-by":"publisher","first-page":"e3540","DOI":"10.1097\/MD.0000000000003540","volume":"95","author":"KH Yu","year":"2016","unstructured":"Yu KH, Kuo CF, Huang LH, Huang WK, See LC. Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan. Medicine. 2016;95(18):e3540.","journal-title":"Medicine"},{"issue":"2","key":"1760_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10549-015-3412-5","volume":"151","author":"W Khaliq","year":"2015","unstructured":"Khaliq W, Qayyum R, Clough J, Vaidya D, Wolff AC, Becker DM. Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population. Breast Cancer Res Treat. 2015;151(2):465\u201374.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"1760_CR23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/0961203313497118","volume":"22","author":"D Dey","year":"2013","unstructured":"Dey D, Kenu E, Isenberg DA. Cancer complicating systemic lupus erythematosus\u2014a dichotomy emerging from a nested case-control study. Lupus. 2013;22(9):919\u201327.","journal-title":"Lupus"},{"key":"1760_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","volume":"42","author":"S Bernatsky","year":"2013","unstructured":"Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun. 2013;42:130\u20135.","journal-title":"J Autoimmun"},{"issue":"6","key":"1760_CR25","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1183\/09031936.00222911","volume":"40","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Respir J. 2012;40(6):1489\u201395.","journal-title":"Eur Respir J"},{"issue":"10","key":"1760_CR26","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1002\/art.30483","volume":"63","author":"L Dreyer","year":"2011","unstructured":"Dreyer L, Faurschou M, Mogensen M, Jacobsen S. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthritis Rheum. 2011;63(10):3032\u20137.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1760_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10067-009-1332-7","volume":"29","author":"KY Kang","year":"2010","unstructured":"Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko HJ, Ju JH, Cho CS, Kim HY, Park SH. Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol. 2010;29(4):381\u20138.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1760_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/sj.bjc.6604906","volume":"100","author":"SM Gadalla","year":"2009","unstructured":"Gadalla SM, Amr S, Langenberg P, Baumgarten M, Davidson WF, Schairer C, Engels EA, Pfeiffer RM, Goedert JJ. Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study. Br J Cancer. 2009;100(5):817\u201321.","journal-title":"Br J Cancer"},{"issue":"8","key":"1760_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s10552-008-9151-8","volume":"19","author":"A Parikh-Patel","year":"2008","unstructured":"Parikh-Patel A, White RH, Allen M, Cress R. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control. 2008;19(8):887\u201394.","journal-title":"Cancer Causes Control"},{"key":"1760_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1196\/annals.1422.008","volume":"1108","author":"T Tarr","year":"2007","unstructured":"Tarr T, Gyorfy B, Szekanecz E, Bhattoa HP, Zeher M, Szegedi G, Kiss E. Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center. Ann N Y Acad Sci. 2007;1108:76\u201382.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"1760_CR31","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/art.21029","volume":"52","author":"S Bernatsky","year":"2005","unstructured":"Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum. 2005;52(5):1481\u201390.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1760_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1191\/0961203303lu443oa","volume":"12","author":"O Ragnarsson","year":"2003","unstructured":"Ragnarsson O, Grondal G, Steinsson K. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus. Lupus. 2003;12(9):687\u201391.","journal-title":"Lupus"},{"issue":"2","key":"1760_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/03009740252937568","volume":"31","author":"L Bjornadal","year":"2002","unstructured":"Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol. 2002;31(2):66\u201371.","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"1760_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1191\/096120301678646128","volume":"10","author":"J Cibere","year":"2001","unstructured":"Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus. 2001;10(6):394\u2013400.","journal-title":"Lupus"},{"issue":"10","key":"1760_CR35","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/rheumatology\/39.10.1147","volume":"39","author":"SM Sultan","year":"2000","unstructured":"Sultan SM, Ioannou Y, Isenberg DA. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology (Oxford). 2000;39(10):1147\u201352.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1760_CR36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/170882679804600507","volume":"46","author":"R Ramsey-Goldman","year":"1998","unstructured":"Ramsey-Goldman R, Mattai SA, Schilling E, Chiu YL, Alo CJ, Howe HL, Manzi S. Increased risk of malignancy in patients with systemic lupus erythematosus. J Invest Med. 1998;46(5):217\u201322.","journal-title":"J Invest Med"},{"issue":"4","key":"1760_CR37","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/art.1780400424","volume":"40","author":"L Mellemkjaer","year":"1997","unstructured":"Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40(4):761\u20138.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1760_CR38","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/art.1780390625","volume":"39","author":"M Abu-Shakra","year":"1996","unstructured":"Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis Rheum. 1996;39(6):1050\u20134.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1760_CR39","first-page":"1478","volume":"22","author":"DM Sweeney","year":"1995","unstructured":"Sweeney DM, Manzi S, Janosky J, Selvaggi KJ, Ferri W, Medsger TA Jr, Ramsey-Goldman R. Risk of malignancy in women with systemic lupus erythematosus. J Rheumatol. 1995;22(8):1478\u201382.","journal-title":"J Rheumatol"},{"issue":"4","key":"1760_CR40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/ard.51.4.437","volume":"51","author":"T Pettersson","year":"1992","unstructured":"Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis. 1992;51(4):437\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1760_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/0961203313520060","volume":"23","author":"J Ni","year":"2014","unstructured":"Ni J, Qiu LJ, Hu LF, Cen H, Zhang M, Wen PF, Wang XS, Pan HF, Ye DQ. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis. Lupus. 2014;23(3):284\u201392.","journal-title":"Lupus"},{"issue":"9","key":"1760_CR42","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/bjc.2011.115","volume":"104","author":"S Bernatsky","year":"2011","unstructured":"Bernatsky S, Ramsey-Goldman R, Foulkes WD, Gordon C, Clarke AE. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis. Br J Cancer. 2011;104(9):1478\u201381.","journal-title":"Br J Cancer"},{"issue":"7","key":"1760_CR43","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00432-014-1604-8","volume":"140","author":"HB Huang","year":"2014","unstructured":"Huang HB, Jiang SC, Han J, Cheng QS, Dong CB, Pan CM. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus. J Cancer Res Clin Oncol. 2014;140(7):1067\u201373.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"1760_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1442-2042.2007.01967.x","volume":"15","author":"KA Hoene","year":"2008","unstructured":"Hoene KA, Kaufman MR, Cates JM, Chang SS. Inflammatory myofibroblastic tumor of the urinary bladder in a 27-year-old woman with systemic lupus erythematosus. Int J Urol. 2008;15(2):182\u20134.","journal-title":"Int J Urol"},{"issue":"2","key":"1760_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7326\/0003-4819-91-2-221","volume":"91","author":"PH Plotz","year":"1979","unstructured":"Plotz PH, Klippel JH, Decker JL, Grauman D, Wolff B, Brown BC, Rutt G. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Ann Intern Med. 1979;91(2):221\u20133.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1760_CR46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1191\/096120300680198926","volume":"9","author":"CC Mok","year":"2000","unstructured":"Mok CC, Lau CS. Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus. 2000;9(4):252\u20137.","journal-title":"Lupus"},{"issue":"1","key":"1760_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-7-1","volume":"7","author":"L Wang","year":"2007","unstructured":"Wang L, Li D, Fu Z, Li H, Wei J, Li D. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer. 2007;7(1):1\u20137.","journal-title":"BMC Cancer"},{"issue":"3","key":"1760_CR48","first-page":"127","volume":"8","author":"A Ghaderi","year":"2011","unstructured":"Ghaderi A. CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iranian J Immunol. 2011;8(3):127.","journal-title":"Iranian J Immunol"},{"issue":"Suppl A","key":"1760_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0896-8411(92)90055-U","volume":"5","author":"LJ Kinlen","year":"1992","unstructured":"Kinlen LJ. Malignancy in autoimmune diseases. J Autoimmun. 1992;5(Suppl A):363\u201371.","journal-title":"J Autoimmun"},{"issue":"8","key":"1760_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1191\/0961203305lu2180xx","volume":"14","author":"BC Chun","year":"2005","unstructured":"Chun BC, Bae SC. Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea. Lupus. 2005;14(8):635\u20138.","journal-title":"Lupus"},{"issue":"2","key":"1760_CR51","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4103\/0973-1482.172115","volume":"12","author":"Y Wu","year":"2016","unstructured":"Wu Y, Hou Q. Systemic lupus erythematous increased lung cancer risk: evidence from a meta-analysis. J Cancer Res Ther. 2016;12(2):721\u20134.","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"1760_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/0961203316664595","volume":"26","author":"S Bernatsky","year":"2017","unstructured":"Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PF, Ginzler E, Romero-Diaz J, Peschken C, Jacobsen S, et al. Breast cancer in systemic lupus. Lupus. 2017;26(3):311\u20135.","journal-title":"Lupus"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1760-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1760-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1760-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:40:08Z","timestamp":1775295608000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1760-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1760-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"15 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"270"}}